The Indian pharma market (IPM) grew 8.3% YoY to Rs 106bn in Oct-16 and 13.0% YoY in 2QFY17. Slow and steady recovery continues post updated NLEM list and confusion over the FDC ban. Notably, volume and price growth was relatively flat at 2.6% and 2.2% YoY respectively in Oct-16.